Association of mTORC1dependent circulating protein levels with cataract formation: a mendelian randomization study

Yingjun Cai1,2, Kangcheng Liu3, Pengfei Wu4

  • 1Eye Center of Xiangya Hospital, Hunan Key Laboratory of Ophthalmology, Central South University, 410008, Changsha, Hunan, China.

BMC Genomics
|October 22, 2022
PubMed
Abstract

Insights

Mendelian randomization study reveals eukaryotic initiation factor 4E-binding protein (EIF4EBP) is a risk factor for cataract development. This suggests the mTORC1/EIF4EBP pathway may be a target for preventing and treating cataracts.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • The mechanistic target of rapamycin (mTOR) pathway is crucial in cataract development.
  • The specific roles of mTORC1 downstream proteins in cataractogenesis remain unclear.

Purpose of the Study:

  • To investigate the causal associations between mTORC1 downstream proteins and cataract development using Mendelian randomization (MR).
  • To explore the potential role of the mTORC1/EIF4EBP axis in cataract formation.

Main Methods:

  • A large-scale Mendelian randomization study was conducted.
  • Genetic variants (SNPs) associated with circulating levels of RP-S6K, EIF4EBP, EIF-4E, EIF-4A, and EIF-4G were identified.
  • Inverse-variance weighted (IVW) and MR robust adjusted profile score (MR. RAPS) methods were employed to assess causal effects.

Main Results:

  • Circulating EIF4EBP and RP-S6K showed a significant causal association with cataract formation.
  • MR. RAPS confirmed the association for EIF4EBP, strengthening confidence in the findings.
  • No significant causal associations were found for EIF-4E, EIF-4A, or EIF-4G with cataract development.

Conclusions:

  • Eukaryotic initiation factor 4E-binding protein (EIF4EBP) is identified as a significant risk factor for cataract development.
  • The mTORC1/EIF4EBP signaling pathway presents a potential causal link to cataract.
  • This study offers insights into cataract mechanisms and identifies a potential genetic target for therapeutic interventions.